Understanding cough in interstitial lung disease: a cross‐sectional study on the adequacy of treatment

Background Cough is a common symptom in interstitial lung disease (ILD), often leading to treatment dissatisfaction for patients and physicians. Aim To identify the prevalence and subjective adequacy of control of cough in patients with ILD. Methods A cross‐sectional study of patients with ILD atten...

Full description

Saved in:
Bibliographic Details
Published in:Internal medicine journal 2021-06, Vol.51 (6), p.923-929
Main Authors: Lan, Norris S. H., Moore, Irene, Lake, Fiona
Format: Article
Language:English
Subjects:
Cough
Cross-sectional studies
Immunosuppression
Immunosuppressive agents
interstitial lung disease
Lung diseases
management
Proton pump inhibitors
Quality of life
Questionnaires
therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Cough is a common symptom in interstitial lung disease (ILD), often leading to treatment dissatisfaction for patients and physicians. Aim To identify the prevalence and subjective adequacy of control of cough in patients with ILD. Methods A cross‐sectional study of patients with ILD attending a tertiary ILD clinic in Perth was undertaken using a pre‐designed questionnaire that patients were invited to complete when attending clinic. Cough severity and impact on quality of life were assessed using a visual analogue scale and the validated Leicester cough questionnaire. Participants were asked to list triggers of their cough and strategies or medications trialled to control cough. Results Of 164 respondents, 118 (72%) had cough, with prevalence common in all ILD subtypes. A lower forced vital capacity (FVC) was found in the cough group versus non‐cough group (74.6 ± 18.7 vs 87.0 ± 15.9, P‐value 
ISSN:1444-0903
1445-5994
DOI:10.1111/imj.14837